HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 72 filers reported holding HARVARD BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,496 | -21.7% | 17,092 | 0.0% | 0.00% | – |
| Q2 2023 | $93,835 | +30.7% | 17,092 | 0.0% | 0.00% | – |
| Q1 2023 | $71,786 | +51.6% | 17,092 | 0.0% | 0.00% | – |
| Q4 2022 | $47,345 | +43.5% | 17,092 | +33.3% | 0.00% | – |
| Q3 2022 | $33,000 | -25.0% | 12,825 | +4.4% | 0.00% | – |
| Q2 2022 | $44,000 | -44.3% | 12,289 | -3.2% | 0.00% | – |
| Q1 2022 | $79,000 | -13.2% | 12,694 | -1.7% | 0.00% | – |
| Q4 2021 | $91,000 | -2.2% | 12,907 | -2.7% | 0.00% | – |
| Q3 2021 | $93,000 | -14.7% | 13,259 | +1.1% | 0.00% | – |
| Q2 2021 | $109,000 | -23.2% | 13,112 | -49.6% | 0.00% | – |
| Q1 2021 | $142,000 | +407.1% | 26,000 | +112.0% | 0.00% | – |
| Q1 2020 | $28,000 | +100.0% | 12,264 | +165.8% | 0.00% | – |
| Q3 2019 | $14,000 | – | 4,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |